Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/24/2003EP1345916A1 Substituted oxazoles and thiazoles as hppar alpha agonists
09/24/2003EP1345914A1 Therapeutic compounds
09/24/2003EP1345913A2 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345903A1 Crystalline forms of cerivastatin sodium
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345901A2 Process for making amlodipine, derivatives thereof, and precursors therefor
09/24/2003EP1345900A1 Guanidine and amidine derivatives as factor xa inhibitors
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345898A2 Teracyclic carbazole derivates and their use as spla2 inhibitors
09/24/2003EP1345896A1 Crystalline forms of atorvastatin
09/24/2003EP1345895A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345682A2 Preparation of microparticles having improved flowability
09/24/2003EP1345633A2 Inhibition of exoprotein production from gram-positive bacteria
09/24/2003EP1345629A2 Particles for inhalation having sustained release properties
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345626A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists
09/24/2003EP1345624A1 Induction of tolerance
09/24/2003EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
09/24/2003EP1345616A2 Reducing cellular damage in the human body
09/24/2003EP1345614A1 IMPROVED AND STABLE EXTRACT FROM i HYPERICUM PERFORATUM L. /i , METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A TOPICAL MEDICAMENT
09/24/2003EP1345613A2 Probiotic compounds derived from lactobacillus casei strain ke01
09/24/2003EP1345612A1 Use of low molecular heparin for treating osteoarthritis
09/24/2003EP1345611A1 An antibiotic/analgesic formulation and a method of making this formulation
09/24/2003EP1345610A1 Method of treatment
09/24/2003EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
09/24/2003EP1345608A2 The use of selective dopamine d4 receptor agonists for treating sexual dysfunction
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1345606A2 Texaphyrin coordination compounds and uses thereof
09/24/2003EP1345605A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril
09/24/2003EP1345604A1 Antitumor therapy comprising distamycin derivatives
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1345602A2 Treatments for neurogenetic disorders, impulse control disorders, and wound healing
09/24/2003EP1345601A2 Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis
09/24/2003EP1345600A1 New clinical treatment
09/24/2003EP1345599A1 Treatment of obsessive compulsive disorder
09/24/2003EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity
09/24/2003EP1345594A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine
09/24/2003EP1345591A1 Pharmaceutical aerosol formulation
09/24/2003EP1345585A1 Compositions for prevention and alleviation of skin wrinkles
09/24/2003EP1345568A2 Stable skin conditioning compositions containing retinoid boosters
09/24/2003EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies
09/24/2003EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof
09/24/2003EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity
09/24/2003EP1272489B1 Process for preparing crystalline form i of cabergoline
09/24/2003EP1268482B1 Pyranoindoles for treating glaucoma
09/24/2003EP1265898B1 1,8-NAPHTHALIMIDE IMIDAZO 4,5,1- i de /i ]ACRIDONES WITH ANTI-TUMOR ACTIVITY
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1224186B1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/24/2003EP1200093B1 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders
09/24/2003EP1200079B1 2-aminotetralin derivatives for the therapy of glaucoma
09/24/2003EP1200065B1 Intravaginal clindamycin ovule composition
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1181302B1 Orally active a1 adenosine receptor agonists
09/24/2003EP1181190B1 Method and apparatus for loading a container with a product
09/24/2003EP1178965B1 Quinoline derivatives as inhibitors of mek enzymes
09/24/2003EP1165558B1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP1124554B1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/24/2003EP1100480B1 Muscarinic antagonists in the treatment of presbyopia
09/24/2003EP1085856B1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/24/2003EP1054868B1 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP1051412B1 Methods for separating a tocotrienol from a tocol-containing mixture and compositions thereof
09/24/2003EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
09/24/2003EP1024137B1 Resolution of amines
09/24/2003EP1021444B1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
09/24/2003EP1011329B1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
09/24/2003EP0999828B1 Method for producing active agent preparations with controlled release from a matrix
09/24/2003EP0986569B1 Process for preparing etoposide
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0982988B1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
09/24/2003EP0973746B1 Substituted 3-cyano quinolines
09/24/2003EP0946190B1 Methods and compositions for stimulating neurite outgrowth
09/24/2003EP0944618B1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
09/24/2003EP0944598B1 Substituted benzamide derivatives and pharmaceutical compositions containing them
09/24/2003EP0938345B1 Aqueous-based pharmaceutical composition
09/24/2003EP0938322B1 Use of uridine triphosphate related compounds for the prevention and treatment of pneumonia in immobilized patients
09/24/2003EP0930880B1 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid
09/24/2003EP0923543B1 Potassium channel inhibitors
09/24/2003EP0920430B1 Purine derivatives and their use as anti-coagulants
09/24/2003EP0914122B1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
09/24/2003EP0904270B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/24/2003EP0876362B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
09/24/2003EP0840735B1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl]
09/24/2003EP0736022B1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
09/24/2003CN1444659A Koji molds and use thereof for preparing cholesterol-lowering products
09/24/2003CN1444601A Regulating lipid levels via the Zmaxl or HBM gene
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/24/2003CN1444596A 16 alpha-methyl or ethyl substituted estrogens
1 ... 5333 5334 5335 5336 5337 5338 5339 5340 5341 5342 5343 5344 5345 5346 5347 5348 5349 5350 5351 5352 5353 ... 7860